AstraZeneca to pay $1.3bn for Ardea

The agreement to purchase the US biotechnology company seeks to secure future sales before patents for key medicines expire

This entry was posted in Company. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *


*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>